Related Experiment Video

Updated: Aug 17, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Socs1 deficiency enhances hepatic insulin signaling

Emma Jamieson1, Mark M W Chong, Gregory R Steinberg

  • 1St. Vincent's Institute of Medical Research, 41 Victoria Parade, Fitzroy, Victoria 3065, Australia.

The Journal of Biological Chemistry
|June 29, 2005
PubMed

Insights

Suppressor of cytokine signaling 1 (SOCS1) deficiency in mice leads to improved hepatic insulin sensitivity and increased insulin receptor substrate 2 (IRS-2) expression. This suggests SOCS1 inhibition as a potential strategy for type 2 diabetes.

Area of Science:

  • Immunology
  • Metabolic diseases
  • Molecular biology

Background:

  • Suppressor of cytokine signaling 1 (SOCS1) is a key negative regulator of cytokine, growth factor, and hormone signaling.
  • Socs1 knockout mice exhibit a severe inflammatory disease, hypoglycemia, and hypoinsulinemia, leading to early mortality.
  • Interferon gamma (IFN-γ) plays a critical role in the inflammatory pathology observed in Socs1-deficient mice.

Purpose of the Study:

  • To investigate the role of SOCS1 in hepatic insulin sensitivity and glucose metabolism.
  • To determine the impact of combined SOCS1 and IFN-γ deficiency on insulin signaling pathways.
  • To explore the therapeutic potential of SOCS1 inhibition in the context of type 2 diabetes.

Main Methods:

  • Generation and analysis of Socs1-/- Ifng-/- mice.
  • Hyperinsulinemic-euglycemic clamp studies to assess insulin sensitivity.
  • Measurement of hepatic insulin receptor substrate 2 (IRS-2) expression and tyrosine phosphorylation.
  • Quantification of phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression.

Main Results:

  • Socs1-/- Ifng-/- mice displayed significantly enhanced hepatic insulin sensitivity compared to controls.
  • Elevated liver IRS-2 expression and tyrosine phosphorylation were observed in Socs1-/- Ifng-/- mice.
  • Reduced hepatic PEPCK mRNA expression was associated with improved insulin sensitivity.
  • These metabolic improvements were not linked to increased hepatic AMP-activated protein kinase activity.

Conclusions:

  • SOCS1 deficiency enhances hepatic insulin sensitivity, partly through increased IRS-2 expression and signaling.
  • The interplay between SOCS1, IFN-γ, and hepatic insulin sensitivity is crucial for glucose homeostasis.
  • Targeting SOCS1 represents a promising therapeutic avenue for managing type 2 diabetes.

More Related Videos

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...